公司資料
Inventiva 股價、新聞與催化劑
- 股票代碼:
- IVA
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- France and listed in the U
股票表現
3.75 USD (-1.06%)
收盤價
最後更新: 2026年9月17日
855M USD
市值
股價為何變動
截至 2026年9月17日，IVA 下跌 1.06%，收於 $3.75。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
Inventiva is a biotechnology company focused on liver disease and fibrotic conditions, especially metabolic and inflammatory pathways. Its story is centered on MASH and related liver biology.
所在地與產業分類
Headquartered in France and listed in the U.S. as an ADR, Inventiva has a global specialty-biopharma profile.
商業模式特徵
The company depends on clinical data, dose selection, and the possibility of building a durable liver-disease franchise.
生技產業定位
Inventiva is a catalyst-sensitive liver-disease name whose stock reacts strongly to clinical progress.
未來催化劑
- Inventiva’s catalyst is lanifibranor, especially the MASH / liver-disease development path and any follow-up that keeps the program on track. The market will watch whether the asset can continue to support a credible metabolic-liver story.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。